JPRN-UMIN000007135已完成未知
Study on effective prevention of chemotherapy-induced nausea and vomiting based on genetic polymorphism - Clinical pharmacogenetics study for antiemetic therapy
nivercity of Shizuoka0 个研究点目标入组 180 人开始时间: 2012年1月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Known prior severe hypersensitivity to anthracyclines, cyclophosphamide, 5HT3 receptor antagonist, corticosteroids and NK-1 receptor antagonists 2) Patients who do not have enough whole body state to the antineoplastic agents treatment 3) Pregnant, breastfeeding or expecting woman 4) Patient with severe uncontrollable diabetes mellitus 5) Known symptomatic brain metastasis 6) Other clinical difficulties in this study
研究者
相似试验
尚未招募
不适用
Music therapy for chemotherapy induced nausea and vomitingCancerACTRN12622001495718Flinders Foundation24
已完成
2 期
Fenretinide in Treating Patients With Leukoplakia of the MouthHead and Neck CancerNCT00004161University of Alabama at Birmingham30
已完成
1 期
Oltipraz in the Prevention of Lung Cancer in People Who SmokeLung CancerNCT00006457Northwestern University
终止
2 期
SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the MouthHead and Neck CancerNCT00003223SWOG Cancer Research Network5
已完成
2 期
Iloprost in Preventing Lung Cancer in Patients at High Risk for This DiseasePrecancerous ConditionLung CancerNCT00084409University of Colorado, Denver152